SI1789398T1 - 2-amino-kinazolinski derivati, uporabni kot inhibitorji b-sekretaze (bace) - Google Patents
2-amino-kinazolinski derivati, uporabni kot inhibitorji b-sekretaze (bace)Info
- Publication number
- SI1789398T1 SI1789398T1 SI200531176T SI200531176T SI1789398T1 SI 1789398 T1 SI1789398 T1 SI 1789398T1 SI 200531176 T SI200531176 T SI 200531176T SI 200531176 T SI200531176 T SI 200531176T SI 1789398 T1 SI1789398 T1 SI 1789398T1
- Authority
- SI
- Slovenia
- Prior art keywords
- bace
- secretase
- inhibitors
- amino
- quinazoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59981004P | 2004-08-06 | 2004-08-06 | |
PCT/IB2005/002595 WO2006024932A1 (en) | 2004-08-06 | 2005-08-08 | 2-amino-quinazoline derivatives useful as inhibitors of b-secretase (bace) |
EP05780525A EP1789398B1 (en) | 2004-08-06 | 2005-08-08 | 2-amino-quinazoline derivatives useful as inhibitors of b-secretase (bace) |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1789398T1 true SI1789398T1 (sl) | 2011-01-31 |
Family
ID=35526992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200531176T SI1789398T1 (sl) | 2004-08-06 | 2005-08-08 | 2-amino-kinazolinski derivati, uporabni kot inhibitorji b-sekretaze (bace) |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1789398B1 (sl) |
JP (1) | JP4898677B2 (sl) |
CN (1) | CN101035772B (sl) |
AT (1) | ATE482936T1 (sl) |
CY (1) | CY1111070T1 (sl) |
DE (1) | DE602005023887D1 (sl) |
DK (1) | DK1789398T3 (sl) |
ES (1) | ES2349594T3 (sl) |
HR (1) | HRP20100594T1 (sl) |
PL (1) | PL1789398T3 (sl) |
PT (1) | PT1789398E (sl) |
RS (1) | RS51631B (sl) |
SI (1) | SI1789398T1 (sl) |
WO (1) | WO2006024932A1 (sl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US8383637B2 (en) | 2004-08-06 | 2013-02-26 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
US8436006B2 (en) | 2004-08-06 | 2013-05-07 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
US8426429B2 (en) | 2004-08-06 | 2013-04-23 | Jansssen Pharmaceutica N.V. | 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
US8722708B2 (en) | 2005-06-14 | 2014-05-13 | Merck Sharp & Dohme Inc. | Substituted isoindolines as aspartyl protease inhibitors |
TWI332005B (en) | 2005-06-14 | 2010-10-21 | Schering Corp | Aspartyl protease inhibitors |
US8686002B2 (en) | 2005-08-21 | 2014-04-01 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as binding partners for 5-HT5 receptors |
EP1966198B1 (en) * | 2005-10-25 | 2011-03-16 | Janssen Pharmaceutica NV | 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace) |
US7776882B2 (en) | 2006-02-06 | 2010-08-17 | Baxter Ellen W | 2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of β-secretase (BACE) |
US7868022B2 (en) | 2006-02-06 | 2011-01-11 | Janssen Pharmaceutica Nv | 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE) |
WO2007092839A2 (en) | 2006-02-06 | 2007-08-16 | Janssen Pharmaceutica N.V. | Macrocycle derivatives useful as inhibitors of beta-secretase (bace) |
US8168641B2 (en) | 2006-06-12 | 2012-05-01 | Schering Corporation | Aspartyl protease inhibitors |
TW200815349A (en) * | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
WO2008073365A1 (en) | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors |
EP1935420A1 (en) * | 2006-12-21 | 2008-06-25 | Merck Sante | 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
CA2687750C (en) * | 2007-07-06 | 2016-10-18 | Boehringer Ingelheim International Gmbh | Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
CN101925578B (zh) | 2008-01-28 | 2012-11-28 | 詹森药业有限公司 | 可用作β-分泌酶(BACE)抑制剂的6-取代-硫代-2-氨基-喹啉衍生物 |
JP2011510993A (ja) * | 2008-01-29 | 2011-04-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | β−セクレターゼ(BACE)阻害剤として有用な2−アミノ−キノリン誘導体 |
AU2009239535A1 (en) | 2008-04-22 | 2009-10-29 | Schering Corporation | Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
WO2011063233A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
TWI411393B (zh) * | 2010-06-14 | 2013-10-11 | Academia Sinica | 乙烯生物合成之化學抑制劑 |
CA2902080A1 (en) | 2013-02-25 | 2014-08-28 | Merck Patent Gmbh | 2-amino-3,4-dihydroquinazoline derivatives and the use thereof as cathepsin d inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2544939B2 (ja) * | 1987-09-01 | 1996-10-16 | 大塚製薬株式会社 | ベンゾヘテロ環誘導体 |
JP2726950B2 (ja) * | 1990-04-27 | 1998-03-11 | 富士写真フイルム株式会社 | カラー画像形成方法 |
US7294642B2 (en) * | 2002-09-06 | 2007-11-13 | Elan Pharmaceuticals, Inc. | 1,3-Diamino-2-hydroxypropane pro-drug derivatives |
WO2004041211A2 (en) * | 2002-11-04 | 2004-05-21 | Georgetown University | INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
-
2005
- 2005-08-08 AT AT05780525T patent/ATE482936T1/de active
- 2005-08-08 CN CN2005800342281A patent/CN101035772B/zh not_active Expired - Fee Related
- 2005-08-08 DK DK05780525.1T patent/DK1789398T3/da active
- 2005-08-08 SI SI200531176T patent/SI1789398T1/sl unknown
- 2005-08-08 RS RS20100565A patent/RS51631B/en unknown
- 2005-08-08 ES ES05780525T patent/ES2349594T3/es active Active
- 2005-08-08 PT PT05780525T patent/PT1789398E/pt unknown
- 2005-08-08 PL PL05780525T patent/PL1789398T3/pl unknown
- 2005-08-08 EP EP05780525A patent/EP1789398B1/en active Active
- 2005-08-08 WO PCT/IB2005/002595 patent/WO2006024932A1/en active Application Filing
- 2005-08-08 DE DE602005023887T patent/DE602005023887D1/de active Active
- 2005-08-08 JP JP2007524423A patent/JP4898677B2/ja not_active Expired - Fee Related
-
2010
- 2010-11-05 HR HR20100594T patent/HRP20100594T1/hr unknown
- 2010-12-29 CY CY20101101201T patent/CY1111070T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1111070T1 (el) | 2015-06-11 |
JP4898677B2 (ja) | 2012-03-21 |
RS51631B (en) | 2011-08-31 |
PT1789398E (pt) | 2010-10-21 |
WO2006024932A1 (en) | 2006-03-09 |
PL1789398T3 (pl) | 2011-03-31 |
EP1789398A1 (en) | 2007-05-30 |
JP2008509129A (ja) | 2008-03-27 |
DK1789398T3 (da) | 2011-01-24 |
ATE482936T1 (de) | 2010-10-15 |
ES2349594T3 (es) | 2011-01-05 |
DE602005023887D1 (de) | 2010-11-11 |
EP1789398B1 (en) | 2010-09-29 |
HRP20100594T1 (hr) | 2010-12-31 |
CN101035772B (zh) | 2011-12-14 |
CN101035772A (zh) | 2007-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1789398T1 (sl) | 2-amino-kinazolinski derivati, uporabni kot inhibitorji b-sekretaze (bace) | |
RS51630B (en) | 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS β-SECRETASE INHIBITORS (BACE) | |
EP1841426A4 (en) | TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
EP1673078A4 (en) | BENZYL ETHER AND BENZYLAMINO BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE | |
TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
PL1966198T3 (pl) | Pochodne 2-amino-3,4-dihydropirydo[3,4-d]pirymidyny do zastosowania jako inhibitory beta-sekretazy (BACE) | |
WO2007092854A3 (en) | 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) | |
WO2007092846A3 (en) | 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE) | |
WO2006044497A3 (en) | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease | |
CY1108146T1 (el) | ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ | |
WO2005004803A3 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | |
IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
MA27556A1 (fr) | Derives de phenylalanine comme inhibiteurs de la dipeptidyl peptidase pour le traitement ou la prevention du diabete | |
WO2005004802A3 (en) | N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
DE60330485D1 (de) | Zur behandlung von diabetes | |
EP1624874A4 (en) | 3-AMINO-4-PHENYLBUTANOIC ACID DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IN THE TREATMENT OR PREVENTION OF DIABETES | |
WO2005065195A3 (en) | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2005051914A8 (en) | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | |
EP1817312A4 (en) | MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
WO2006078576A3 (en) | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2006057945A3 (en) | 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | |
EP2091328A4 (en) | SPIROPIPERIDININHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER DISEASE | |
WO2007058862A3 (en) | Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2007092839A3 (en) | Macrocycle derivatives useful as inhibitors of beta-secretase (bace) |